Loading
WD-940 is an experimental small molecule from Zhejiang Wenda Pharma, in preclinical development for advanced cancer; its current status is not stated.
WD-940 is a small molecule from Zhejiang Wenda Pharma. Described only as a brain-penetrant inhibitor of a mutant protein; the company compares it with BI-1810631 and NVL-330 but does not name the target. Its furthest stage is preclinical development, for advanced cancer (unspecified). No clinical trial naming it is registered on ClinicalTrials.gov. The page said WD-940 was expected to enter the clinic in 2024; no registered trial was found on ClinicalTrials.gov. It has not been shown to work in people.
Described only as a brain-penetrant inhibitor of a mutant protein; the company compares it with BI-1810631 and NVL-330 but does not name the target.
1.WD-940 slips into a pocket on its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"WD-940" OR ABSTRACT:"WD-940") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about WD-940, not a curated reading list.
Shares Zhejiang Wenda Pharma, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Zhejiang Wenda Pharma, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Zhejiang Wenda Pharma and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/